We are experts in formulating and developing of transdermal pharmaceutical products. By offering a combination of development and direct manufacture, Greene Street is well positioned to benefit the lives of patients and physicians. With Transdermal Innovative Products (TiPs®) currently scheduled for animal studies and human clinical trials, Greene Street is able to unleash it's sizable pipeline for license. Our Transdermal Innovative Products match comparative oral drug specifications and efficacy, adhere to current FDA rules and guidelines, alleviate the majority of GI side effects encountered in oral drugs, and help improve delivery for patients with swallowing difficulties.